Abstract
Economic evaluations of new technologies often assess the cost-effectiveness for a typical patient or budget impact for payers. This analysis projects potential costs, health gains, and productivity gains at a national population-level based on more patients receive a surgical tissue valve vs. mechanical valve replacement.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
